Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04291885
What this trial is testing

Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

Who this might be right for
Merkel Cell CarcinomaMerkel Cell Carcinoma, Stage IMerkel Cell Carcinoma, Stage II+3 more
Melanoma and Skin Cancer Trials Limited 122
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110558
What this trial is testing

Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 59
Testing effectiveness (Phase 2)Looking for participantsNCT05825443
What this trial is testing

Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients

Who this might be right for
ImmunotherapyChemotherapy
Nanfang Hospital, Southern Medical University 57
Large-scale testing (Phase 3)Not Yet RecruitingNCT06089369
What this trial is testing

Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion

Who this might be right for
Hepatocellular Carcinoma
Tongji Hospital 360
Early research (Phase 1)Ended earlyNCT01313429
What this trial is testing

Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum

Who this might be right for
SarcomaMelanomaEpithelial Malignancies+1 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Looking for participantsNCT07530094
What this trial is testing

Short-Course Definitive Chemoradiotherapy Combined With Adjuvant or Concurrent Plus Adjuvant Camrelizumab for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Ning Jiang, M.D./Ph.D. 98
Testing effectiveness (Phase 2)WithdrawnNCT05545969
What this trial is testing

Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma

Who this might be right for
Mucosal Melanoma
Melanoma Institute Australia
Early research (Phase 1)Study completedNCT02721043
What this trial is testing

Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies

Who this might be right for
Solid Tumors
Nina Bhardwaj 13
Large-scale testing (Phase 3)Study completedNCT00636168
What this trial is testing

Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma

Who this might be right for
High Risk Stage III Melanoma
Bristol-Myers Squibb 1,211
Testing effectiveness (Phase 2)Active Not RecruitingNCT06094140
What this trial is testing

NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Australasian Gastro-Intestinal Trials Group 20
Large-scale testing (Phase 3)UnknownNCT04682210
What this trial is testing

Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection

Who this might be right for
HCCAdjuvant TherapyImmunotherapy
Sun Yat-sen University 246
Testing effectiveness (Phase 2)Looking for participantsNCT07027124
What this trial is testing

Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer

Who this might be right for
Prostate CancerHigh-risk Prostate Cancer
Icahn School of Medicine at Mount Sinai 40
Large-scale testing (Phase 3)Ended earlyNCT04410445
What this trial is testing

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

Who this might be right for
MelanomaMelanoma Stage IIIMelanoma Stage IV+1 more
Nektar Therapeutics 765
Testing effectiveness (Phase 2)Looking for participantsNCT06078384
What this trial is testing

Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC

Who this might be right for
Triple-negative Breast Cancer
UNICANCER 354
Testing effectiveness (Phase 2)UnknownNCT02715882
What this trial is testing

Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
BioLab 612 LLC 40
Not applicableNo Longer AvailableNCT07083479
What this trial is testing

Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaKRAS G12DKRAS G12V+12 more
Elicio Therapeutics
Early research (Phase 1)Active Not RecruitingNCT04270149
What this trial is testing

Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer

Who this might be right for
Breast Cancer
Herbert Lyerly 8
Not applicableStudy completedNCT06298123
What this trial is testing

Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling

Who this might be right for
Hepatocellular CarcinomaAdjuvant ImmunotherapyCheckpoint Inhibitor
Chen Xiaoping 304
Testing effectiveness (Phase 2)WithdrawnNCT03574649
What this trial is testing

QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
ImmunityBio, Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07033143
What this trial is testing

Evaluation of the Efficacy and Safety of Adebrelimab Combined With SOX as Adjuvant Therapy for IIIB and IIIC Gastric Cancer

Who this might be right for
Gastric Cance
Tianjin Medical University Cancer Institute and Hospital 40
Next Page